⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VRCA News
Verrica Pharmaceuticals Inc. Common Stock
Form 8-K
sec.gov
VRCA
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
globenewswire.com
VRCA
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
globenewswire.com
VRCA
Form 8-K
sec.gov
VRCA
Verrica Pharmaceuticals Reports First Quarter 2026 Financial Results
globenewswire.com
VRCA
Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting
globenewswire.com
VRCA
Verrica Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 12, 2026
globenewswire.com
VRCA
Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting
globenewswire.com
VRCA
Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference
globenewswire.com
VRCA
VRCA Investors Have the Opportunity to Join Investigation of Verrica Pharmaceuticals Inc. with the Schall Law Firm
businesswire.com
VRCA